AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8029793 — intervention group
Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (LMWH) - 4 different LMWHs
Number of subjects: 0
Study 2644719 — intervention group
Group type: EXPERIMENTAL
Intervention: Intercostal blockade with bupivacaine supplemented with papaveretum
Number of subjects: 66
Study 2644719 — intervention group
Group type: COMPARATOR
Intervention: Papaveretum alone
Number of subjects: 66
Study 1035148 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A acid (retinoic acid)
Number of subjects: 405
Study 31477178 — intervention group
Group type: EXPERIMENTAL
Intervention: EASE intervention (group-based, seven sessions for adolescents, three sessions for caregivers)
Number of subjects: 445
Study 31477178 — intervention group
Group type: COMPARATOR
Intervention: Enhanced usual care (one home-visit psychoeducation session)
Number of subjects: 445
Study 31477178 — intervention group
Group type: EXPERIMENTAL
Intervention: EASE intervention
Number of subjects: 445
Study 28693854 — intervention group
Group type: EXPERIMENTAL
Intervention: bOPV and one dose of IPV
Number of subjects: 939
Study 28693854 — intervention group
Group type: EXPERIMENTAL
Intervention: bOPV and two doses of IPV
Number of subjects: 939
Study 28693854 — intervention group
Group type: COMPARATOR
Intervention: tOPV
Number of subjects: 939
Study 25711726 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam 7.5 mg
Number of subjects: 120
Study 25711726 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam 10.0 mg
Number of subjects: 120
Study 25711726 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 23078888 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferric carboxymaltose (FCM)
Number of subjects: 204
Study 23078888 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 204
Study 20689464 — intervention group
Group type: EXPERIMENTAL
Intervention: Tibolone 1.25 mg/day
Number of subjects: 80
Study 20689464 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 19653786 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocaine (175 mg, p.o.; 5 hourly doses; 875 mg/day)
Number of subjects: 9
Study 19653786 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 16442902 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate drinking (7-13 drinks per week)
Number of subjects: 1351
Study 16442902 — intervention group
Group type: EXPERIMENTAL
Intervention: High-density lipoprotein cholesterol
Number of subjects: 1351
Study 16442902 — intervention group
Group type: COMPARATOR
Intervention: Low-dose warfarin or placebo
Number of subjects: 1351
Study 16442902 — intervention group
Group type: COMPARATOR
Intervention: Lovastatin in low or high doses
Number of subjects: 1351
Study 15277738 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training under supervision at the anaerobic threshold level for 2 weeks
Number of subjects: 36
Study 15277738 — intervention group
Group type: COMPARATOR
Intervention: Conventional walking regimen
Number of subjects: 36
Study 11117101 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided visualization tape
Number of subjects: 0
Study 11117101 — intervention group
Group type: COMPARATOR
Intervention: Visual search task (Control)
Number of subjects: 0
Study 9099773 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary care (with care for acute illnesses also provided in the follow-up clinic)
Number of subjects: 484
Study 9099773 — intervention group
Group type: COMPARATOR
Intervention: Conventional care after nursery discharge (with well-baby care and care for chronic illnesses provided in our follow-up clinic)
Number of subjects: 484
Study 9099773 — intervention group
Group type: COMPARATOR
Intervention: Conventional care
Number of subjects: 484
Study 9099773 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary care
Number of subjects: 484
Study 8360130 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftazidime 2 g bid
Number of subjects: 393
Study 8360130 — intervention group
Group type: COMPARATOR
Intervention: Imipenem/cilastatin 0.5 g qid
Number of subjects: 393
Study 3098997 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical therapy thrice weekly (PT3)
Number of subjects: 30
Study 3098997 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical therapy five times weekly (PT5)
Number of subjects: 30
Study 3098997 — intervention group
Group type: COMPARATOR
Intervention: No therapy (controls)
Number of subjects: 30
Study 31526206 — intervention group
Group type: EXPERIMENTAL
Intervention: Cabergoline (1 mg)
Number of subjects: 0
Study 31526206 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 27353076 — intervention group
Group type: EXPERIMENTAL
Intervention: External Hexagon (EH) implants
Number of subjects: 12
Study 27353076 — intervention group
Group type: EXPERIMENTAL
Intervention: Morse-Taper (MT) implants
Number of subjects: 12
Study 25921850 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet (MeDiet)
Number of subjects: 7447
Study 25921850 — intervention group
Group type: COMPARATOR
Intervention: Control diet (advice on a low-fat diet)
Number of subjects: 7447
Study 23476148 — intervention group
Group type: EXPERIMENTAL
Intervention: Proximal femur nail antirotation (PFNA)
Number of subjects: 87
Study 23476148 — intervention group
Group type: COMPARATOR
Intervention: Reverse less invasive stabilisation system (LISS)
Number of subjects: 87
Study 21610529 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant activated factor VII (rFVIIa)
Number of subjects: 560
Study 21610529 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 560
Study 19170724 — intervention group
Group type: EXPERIMENTAL
Intervention: nebivolol
Number of subjects: 52
Study 16794641 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical traction at 7.5% total body weight (TBW)
Number of subjects: 60
Study 16794641 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical traction at 10% total body weight (TBW)
Number of subjects: 60
Study 16794641 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical traction at 15% total body weight (TBW)
Number of subjects: 60
Study 16794641 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical traction (all weights)
Number of subjects: 60
Study 15486152 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic Touch (20 minutes daily for 7 days)
Number of subjects: 54
Study 15486152 — intervention group
Group type: COMPARATOR
Intervention: Shared activity with a registered nurse (20 minutes daily for 7 days)
Number of subjects: 54
Study 15486152 — intervention group
Group type: COMPARATOR
Intervention: Standard ward care
Number of subjects: 54
Study 11685163 — intervention group
Group type: EXPERIMENTAL
Intervention: Cutting Balloon angioplasty (CBA)
Number of subjects: 248
Study 11685163 — intervention group
Group type: COMPARATOR
Intervention: Conventional balloon angioplasty (PTCA)
Number of subjects: 248
Study 9129918 — intervention group
Group type: EXPERIMENTAL
Intervention: Nephrectomy
Number of subjects: 69
Study 9129918 — intervention group
Group type: COMPARATOR
Intervention: No risk factors (control group)
Number of subjects: 69
Study 8183657 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer support group
Number of subjects: 0
Study 8183657 — intervention group
Group type: EXPERIMENTAL
Intervention: Selected partner support group
Number of subjects: 0
Study 8183657 — intervention group
Group type: COMPARATOR
Intervention: No-support control group
Number of subjects: 0
Study 3282572 — intervention group
Group type: EXPERIMENTAL
Intervention: Filtered products
Number of subjects: 40
Study 3282572 — intervention group
Group type: COMPARATOR
Intervention: Standard unfiltered products (Control)
Number of subjects: 40
Study 31612292 — intervention group
Group type: EXPERIMENTAL
Intervention: Jacki Jacket (JJ)
Number of subjects: 139
Study 31612292 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 139
Study 29882388 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunotherapy treatments with various doses (specific dosages not mentioned)
Number of subjects: 0
Study 29882388 — intervention group
Group type: EXPERIMENTAL
Intervention: Safe doses identified in the first stage of the trial
Number of subjects: 0
Study 29882388 — intervention group
Group type: EXPERIMENTAL
Intervention: SPIRIT trial design
Number of subjects: 0
Study 27805299 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine
Number of subjects: 129
Study 27805299 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium carbonate
Number of subjects: 129
Study 24341527 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.03 mg MRrhTSH
Number of subjects: 95
Study 24341527 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.01 mg MRrhTSH
Number of subjects: 95
Study 24341527 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95
Study 24341527 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.03 mg MRrhTSH (subgroup with basal (131)I uptake <20%)
Number of subjects: 95
Study 24341527 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.01 mg MRrhTSH (subgroup)
Number of subjects: 95
Study 24341527 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of Life (QoL)
Number of subjects: 95
Study 22486146 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.2 mm incision group
Number of subjects: 60
Study 22486146 — intervention group
Group type: COMPARATOR
Intervention: 3.0 mm incision group
Number of subjects: 60
Study 20937921 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist-physician collaborative management of hypertension
Number of subjects: 179
Study 20937921 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 179
Study 18772809 — intervention group
Group type: EXPERIMENTAL
Intervention: ERG-jet electrode
Number of subjects: 27
Study 18772809 — intervention group
Group type: COMPARATOR
Intervention: Gold Foil electrode
Number of subjects: 27
Study 15854463 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopy group
Number of subjects: 40
Study 15854463 — intervention group
Group type: COMPARATOR
Intervention: Laparotomy group
Number of subjects: 40
Study 11170947 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaqta
Number of subjects: 537
Study 11170947 — intervention group
Group type: COMPARATOR
Intervention: Havrix
Number of subjects: 537
Study 9510281 — intervention group
Group type: EXPERIMENTAL
Intervention: Cilostazol (100 mg b.i.d.)
Number of subjects: 239
Study 9510281 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 239
Study 8043291 — intervention group
Group type: EXPERIMENTAL
Intervention: Preconditioning (two 3-min periods of cross-clamping separated by 2 min of reperfusion)
Number of subjects: 20
Study 8043291 — intervention group
Group type: COMPARATOR
Intervention: Control (10 min cross-clamping with fibrillation without prior preconditioning)
Number of subjects: 20
Study 3394980 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg IM butorphanol
Number of subjects: 18
Study 3394980 — intervention group
Group type: COMPARATOR
Intervention: 6 mg IM morphine
Number of subjects: 18
Study 31811010 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based warfarin anticoagulation management model
Number of subjects: 700
Study 31811010 — intervention group
Group type: COMPARATOR
Intervention: Traditional outpatient anticoagulation management
Number of subjects: 700
Study 28943074 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI delineation (Center B, n=170, 7-mm margins)
Number of subjects: 572
Study 28943074 — intervention group
Group type: EXPERIMENTAL
Intervention: Endorectal balloon (ERB) application (Center C, n=85, 7-mm margins)
Number of subjects: 572
Study 28943074 — intervention group
Group type: COMPARATOR
Intervention: Conventional fractionated radiation therapy (78 Gy in 39 fractions)
Number of subjects: 572
Study 28943074 — intervention group
Group type: COMPARATOR
Intervention: Hypofractionated radiation therapy (64.6 Gy in 19 fractions)
Number of subjects: 572
Study 23301875 — intervention group
Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 (400 mg) and selenium (200 μg) supplementation for 12 weeks
Number of subjects: 43
Study 23301875 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study 20844095 — intervention group
Group type: EXPERIMENTAL
Intervention: Prehospital non-invasive ventilation (NIV)
Number of subjects: 36
Study 20844095 — intervention group
Group type: COMPARATOR
Intervention: Standard oxygen therapy
Number of subjects: 36
Study 19291083 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-day communication course for clinicians
Number of subjects: 1395
Study 19291083 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 1395
Study 16752942 — intervention group
Group type: COMPARATOR
Intervention: ASA 500 mg
Number of subjects: 50
Study 16752942 — intervention group
Group type: EXPERIMENTAL
Intervention: ASA + EGb 761 240 mg
Number of subjects: 50
Study 15087629 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal analgesia (bupivacaine 15 mg, clonidine 75 microg, morphine 0.2 mg)
Number of subjects: 100
Study 15087629 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia supplemented with intravenous fentanyl
Number of subjects: 100
Study 11576197 — intervention group
Group type: EXPERIMENTAL
Intervention: rizatriptan ODT 10-mg
Number of subjects: 524
Study 11576197 — intervention group
Group type: COMPARATOR
Intervention: sumatriptan 50-mg tablet
Number of subjects: 524
Study 9767742 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative autologous blood donation
Number of subjects: 190
Study 9767742 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute normovolemic hemodilution
Number of subjects: 190
Study 9767742 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative erythropoietin therapy with acute normovolemic hemodilution
Number of subjects: 190
Study 9767742 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 190
Study 8144779 — intervention group
Group type: EXPERIMENTAL
Intervention: Active drug
Number of subjects: 3840
Study 8144779 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3840
Study 8144779 — intervention group
Group type: EXPERIMENTAL
Intervention: Active drug and Placebo
Number of subjects: 3840
Study 8144779 — intervention group
Group type: EXPERIMENTAL
Intervention: First drug tested
Number of subjects: 3840
Study 8144779 — intervention group
Group type: EXPERIMENTAL
Intervention: Second drug tested
Number of subjects: 3840
Study 8144779 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased ventricular premature depolarizations
Number of subjects: 3840
Study 2556484 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfa LMWH 7500 anti-Xa coagulometric units twice daily
Number of subjects: 49
Study 2556484 — intervention group
Group type: COMPARATOR
Intervention: UFH 5000 IU t.i.d.
Number of subjects: 49
Study 30891605 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent preventive treatment of malaria in pregnancy (IPTp)
Number of subjects: 637
Study 30891605 — intervention group
Group type: EXPERIMENTAL
Intervention: Parasitemia detected during pregnancy
Number of subjects: 637
Study 30891605 — intervention group
Group type: EXPERIMENTAL
Intervention: Parasitemia detected only before the third trimester
Number of subjects: 637
Study 30891605 — intervention group
Group type: COMPARATOR
Intervention: No parasitemia detected during pregnancy
Number of subjects: 637
Study 28768800 — intervention group
Group type: EXPERIMENTAL
Intervention: Authorization to randomize in both trials
Number of subjects: 147
Study 28768800 — intervention group
Group type: EXPERIMENTAL
Intervention: Principal investigator specialties of interventional radiology and cardiology
Number of subjects: 147
Study 28768800 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre‐trial reported performance >50 carotid angioplasty and stenting procedures per year
Number of subjects: 147
Study 28768800 — intervention group
Group type: EXPERIMENTAL
Intervention: Status in the top half of recruitment in the CREST trial
Number of subjects: 147
Study 28768800 — intervention group
Group type: EXPERIMENTAL
Intervention: Classification as a private health facility
Number of subjects: 147
Study 28768800 — intervention group
Group type: COMPARATOR
Intervention: Participation in StrokeNet
Number of subjects: 147
Study 28768800 — intervention group
Group type: EXPERIMENTAL
Intervention: Median time between site selection to authorization to randomize
Number of subjects: 147
Study 28768800 — intervention group
Group type: EXPERIMENTAL
Intervention: Median time between authorization to randomize and a randomization
Number of subjects: 147
Study 28768800 — intervention group
Group type: EXPERIMENTAL
Intervention: Recruitment rate
Number of subjects: 147
Study 26049544 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-delivered counselling intervention
Number of subjects: 20
Study 26049544 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 20
Study 24134367 — intervention group
Group type: EXPERIMENTAL
Intervention: P4 for Women
Number of subjects: 134
Study 24134367 — intervention group
Group type: COMPARATOR
Intervention: SISTA
Number of subjects: 134
Study 21269509 — intervention group
Group type: EXPERIMENTAL
Intervention: DECISION+2 intervention group (experimental group)
Number of subjects: 700
Study 21269509 — intervention group
Group type: COMPARATOR
Intervention: No-intervention control group
Number of subjects: 700
Study 19843681 — intervention group
Group type: EXPERIMENTAL
Intervention: E‐only (estrogen alone)
Number of subjects: 67412
Study 19843681 — intervention group
Group type: EXPERIMENTAL
Intervention: E‐only for <5 years
Number of subjects: 67412
Study 19843681 — intervention group
Group type: EXPERIMENTAL
Intervention: E‐only for >or=20 years
Number of subjects: 67412
Study 19843681 — intervention group
Group type: EXPERIMENTAL
Intervention: E + P (estrogen plus progesterone)
Number of subjects: 67412
Study 19843681 — intervention group
Group type: COMPARATOR
Intervention: Never used postmenopausal hormones
Number of subjects: 67412
Study 16798698 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole 750 mg 3 times daily + S. boulardii 250 mg b.i.d. orally for 10 days
Number of subjects: 65
Study 16798698 — intervention group
Group type: COMPARATOR
Intervention: Metronidazole 750 mg 3 times daily + placebo (empty capsules) for 10 days
Number of subjects: 65
Study 15985128 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine wound infiltration 0.5%; 10 mL, followed by continuous infusion: 10 mg/24 H
Number of subjects: 47
Study 15985128 — intervention group
Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 47
Study 12660513 — intervention group
Group type: EXPERIMENTAL
Intervention: Tac triple therapy (n=185)
Number of subjects: 555
Study 12660513 — intervention group
Group type: EXPERIMENTAL
Intervention: ATG induction with tacrolimus (ATG-Tac, n=186)
Number of subjects: 555
Study 12660513 — intervention group
Group type: EXPERIMENTAL
Intervention: ATG induction with CsA (ATG-CsA, n=184)
Number of subjects: 555
Study 10624454 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 (440 IU) and Calcium (500 mg, 1250 mg calcium carbonate, Novartis) twice daily
Number of subjects: 248
Study 10624454 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 248
Study 8669348 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength exercise group
Number of subjects: 86
Study 8669348 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobility exercise group
Number of subjects: 86
Study 8669348 — intervention group
Group type: COMPARATOR
Intervention: Health education group
Number of subjects: 86
Study 2172501 — intervention group
Group type: EXPERIMENTAL
Intervention: 2',3'-dideoxycytidine (ddC) at 0.015, 0.02, 0.03, and 0.04 mg/kg, given orally every 6 hours for 8 weeks
Number of subjects: 15
Study 2172501 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternating schedule of ddC for 1 week followed by AZT (180 mg/m2 every 6 hours) for 3 weeks
Number of subjects: 15
Study 371371 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate aerosol, 50 mcg into each nostril four times a day
Number of subjects: 30
Study 371371 — intervention group
Group type: COMPARATOR
Intervention: Placebo aerosol therapy
Number of subjects: 30
Study 31846113 — intervention group
Group type: EXPERIMENTAL
Intervention: Hip-focused exercise
Number of subjects: 112
Study 31846113 — intervention group
Group type: EXPERIMENTAL
Intervention: Knee-focused exercise
Number of subjects: 112
Study 31846113 — intervention group
Group type: EXPERIMENTAL
Intervention: Free physical activity
Number of subjects: 112
Study 30817495 — intervention group
Group type: EXPERIMENTAL
Intervention: TTFields with maintenance TMZ
Number of subjects: 0
Study 30817495 — intervention group
Group type: COMPARATOR
Intervention: TMZ alone
Number of subjects: 0
Study 28055230 — intervention group
Group type: EXPERIMENTAL
Intervention: Faster aspart
Number of subjects: 43
Study 28055230 — intervention group
Group type: COMPARATOR
Intervention: IAsp
Number of subjects: 43
Study 25984803 — intervention group
Group type: EXPERIMENTAL
Intervention: Maudsley Model of Anorexia Nervosa Treatment for Adults (MANTRA)
Number of subjects: 142
Study 25984803 — intervention group
Group type: COMPARATOR
Intervention: Specialist Supportive Clinical Management (SSCM)
Number of subjects: 142
Study 23765764 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentax-AWS (AWS)
Number of subjects: 31
Study 23765764 — intervention group
Group type: COMPARATOR
Intervention: Macintosh laryngoscope (McL)
Number of subjects: 31
Study 21244240 — intervention group
Group type: EXPERIMENTAL
Intervention: Synbiotic product (3 tablets per day, 2.4 × 10^9 colony-forming units/day)
Number of subjects: 36
Study 21244240 — intervention group
Group type: EXPERIMENTAL
Intervention: Synbiotic product
Number of subjects: 36
Study 21244240 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 19591795 — intervention group
Group type: EXPERIMENTAL
Intervention: AMA1 vaccine
Number of subjects: 0
Study 17001106 — intervention group
Group type: EXPERIMENTAL
Intervention: GH treatment at 0.012 mg/kg/day for 24 weeks, followed by individualized dosing for another 24 weeks.
Number of subjects: 27
Study 15799935 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular repair (ER)
Number of subjects: 342
Study 15799935 — intervention group
Group type: COMPARATOR
Intervention: Open repair (OR)
Number of subjects: 342
Study 10699140 — intervention group
Group type: EXPERIMENTAL
Intervention: Formula containing 12 mg/L of iron
Number of subjects: 493
Study 10699140 — intervention group
Group type: EXPERIMENTAL
Intervention: Formula containing 0.9 mg/L of iron
Number of subjects: 493
Study 10699140 — intervention group
Group type: COMPARATOR
Intervention: Cow's milk
Number of subjects: 493